TL;DR
Get health and wellness essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A new Veterans Affairs policy for younger veterans calls for signed consent and documented discussions of antidepressant risks and benefits before prescribing. Separately, a randomized trial found an investigational app reduced negative symptom severity in schizophrenia, and a small pilot trial linked reduced ultraprocessed food intake with lower depression and anxiety scores. The studies and policy have different scopes, and details about implementation and clinical effects remain limited.
The Department of Veterans Affairs will require younger veterans to sign consent forms and have documented discussions about antidepressant risks and benefits before receiving a prescription, according to a report cited by MedpageToday. The same September 30 psychiatry roundup also described a randomized trial of a schizophrenia app and a small diet study in major depression, developments that may inform future care but do not establish that either approach works for every patient.
The VA policy, reported by The New York Times, applies to younger veterans seeking antidepressant prescriptions. The reported requirements are a signed consent form and documentation that risks and benefits were discussed. The roundup did not specify the age range covered, when the policy takes effect, which medications are included, or how clinicians will document the conversations.
In a randomized trial published in JAMA Network Open, an investigational smartphone app reduced the severity of negative symptoms in people with schizophrenia, the roundup reported. Negative symptoms can include reduced motivation or social engagement. The available summary does not provide the trial’s size, the app’s features, the length of follow-up, or the size of the measured change.
A small pilot crossover trial published in JAMA Psychiatry reported lower depression and anxiety scores among patients with major depressive disorder when they reduced the amount of ultraprocessed food in their diets. The result describes an association observed under the study conditions. The roundup did not give participant numbers, the duration of each diet period, or details about how food intake changed.
Changes to Prescribing and Care Research
The VA requirement formalizes two steps before antidepressant prescribing for the affected veterans: a discussion of potential risks and benefits, and a record that the discussion took place. Consent and documentation can make treatment decisions more explicit for patients and clinicians. The report does not say that the policy bars prescriptions or changes which antidepressants may be prescribed.
The app and diet findings point to areas researchers are testing alongside established mental health care. An app that reduces negative symptom severity could be relevant to people whose symptoms affect day-to-day functioning, while dietary changes may merit further study for depression. But one trial does not establish routine effectiveness, and the diet result came from a small pilot. Neither summary supports replacing prescribed care with an app or dietary changes.
For readers, the developments have distinct practical status. The VA policy is a reported administrative change for a defined patient group; the app and diet are research findings. Study results do not amount to individual treatment advice. People considering changes to psychiatric medication or care should discuss them with a qualified clinician.
Top picks for "antidepressant aids schizophrenia"
As an affiliate, we earn on qualifying purchases.
Three Developments, Different Evidence
The source is a short psychiatry roundup published by MedpageToday on September 30, 2026. It drew on separate reports and studies rather than describing one coordinated program. The VA item was attributed to The New York Times; the app trial was reported in JAMA Network Open; and the diet trial appeared in JAMA Psychiatry.
The app finding concerns negative symptoms in schizophrenia, not all symptoms or all people with the condition. The diet report concerns patients with major depressive disorder and measured depression and anxiety scores after participants reduced ultraprocessed foods. These populations, interventions and outcomes differ, so the results should not be treated as directly comparable.
The roundup also included other mental health news, including national suicide statistics and reports of suicide attempts among sailors. Those items provide wider public health context, but they are separate developments from the VA policy and the two studies covered here. The source does not link them causally.
“An investigational smartphone app reduced the severity of negative symptoms in schizophrenia.”
— MedpageToday summary of the randomized trial
Policy Scope and Trial Details
The available report does not state which ages qualify as younger veterans, when the VA policy starts, or whether it applies to every antidepressant prescription. The full policy and guidance for clinicians were not included in the roundup, so its operational requirements cannot be fully assessed from this account.
For the app study, key details remain absent from the summary: sample size, comparison condition, symptom scale, follow-up period and whether effects lasted after the trial. The findings are reported as a reduction in symptom severity, but the magnitude and duration of the change are not given.
The diet study summary likewise omits the number of participants, the precise dietary changes and the period over which scores were measured. It does not establish whether reduced ultraprocessed food intake caused the reported score changes or whether the results apply beyond the pilot sample. Replication and fuller study data would help clarify the finding’s relevance.
Implementation and Further Study
The next practical milestone for the VA policy is clearer information on its effective date, covered age group and clinician guidance. Those details would show how the consent and documentation requirements will work in appointments and whether they affect prescribing processes.
For the app, further reporting or publication details could clarify the trial design, size of the measured benefit and whether researchers plan longer follow-up or additional testing. Those results would help establish whether the app merits broader evaluation as part of schizophrenia care.
The diet finding will need confirmation in larger or repeated studies to show whether the reported changes in depression and anxiety scores persist and under what conditions. Until such evidence is available, the roundup supports describing the result as preliminary research. No next publication dates or trial milestones were specified in the source material.
Key Questions
What does the new VA antidepressant policy require?
According to the report cited by MedpageToday, younger veterans must sign a consent form and have a documented discussion of antidepressant risks and benefits before receiving a prescription.
Does the VA policy prohibit antidepressant prescriptions?
The source describes consent and documentation requirements. It does not report a ban on prescriptions or a change to which antidepressants clinicians may prescribe.
What did the schizophrenia app trial find?
The randomized trial summary says an investigational smartphone app reduced the severity of negative symptoms. It does not provide the size or duration of the change.
Does the diet study prove that avoiding ultraprocessed foods treats depression?
No. The small pilot crossover trial reported lower depression and anxiety scores when participants reduced ultraprocessed foods. The summary does not establish that the change caused the results or that they apply to everyone.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
